arrow
Back
F

Feyruz V. Rassool

university of maryland

40H-index
243Paper Count
5.6KCitation Count
Published Papers 48
Publication Date
A phase 1 study of ASTX727 plus talazoparib in patients with triple-negative or hormone resistant/HER2-negative metastatic breast cancer
errCancer
IF5.1
err2026-04-14
err0
errOAAI
errKathy D. Miller MD; Alexandra Thomas MD; Sandra Althouse MS; Yong Zang PhD; Erin Conder MS, CCRP; Ryan Burgos BS, MBA; Bryan P. Schneider MD; Tarah Ballinger MD; Emily Douglas MD; Katherine Ansley MD; H. Josh Jang PhD; Woonbok Chung PhD; Jean-Pierre Issa PhD; Kenneth P. Nephew PhD; Feyruz V. Rassool PhD
errShare
errSave
The Epigenetic Hallmarks of Cancer
err2024-10-04
err2
PREAI
errEsteller, Manel; Dawson, Mark A.; Kadoch, Cigall; Rassool, Feyruz V.; Jones, Peter A.; Baylin, Stephen B.
errShare
errSave
ZNFX1 is a master regulator and tumor suppressor in epigenetically induced pathogen mimicry, mitochondrial dysfunction and STING-dependent signaling in cancer
err2024-03-22
err0
PREAI
errStojanovic, Lora; Abbotts, Rachel; Tripathi, Kaushlendra; Coon, Collin M.; Liu, Sheng; Wan, Jun; Topper, Michael; Baylin, Stephen; Nephew, Kenneth; Rassool, Feyruz
errShare
errSave
ZNFX1 is a master regulator for epigenetic reprograming of mitochondrial inflammasome signaling and pathogen mimicry in cancer cells
err2024-03-04
err0
PREAI
errStojanovic, Lora; Abbotts, Rachel; Tripathi, Kaushlendra; Coon, Collin M.; Liu, Sheng; Wan, Jun; Topper, Michael J.; Nephew, Kenneth P.; Baylin, Stephen B.; Rassool, Feyruz V.
errShare
errSave
Activating STING1-dependent immune signaling in TP53 mutant and wild-type acute myeloid leukemia
err2022-06-27
err15
errOAAI
errKogan, Aksinija A.; Topper, Michael J.; Dellomo, Anna J.; Stojanovic, Lora; McLaughlin, Lena J.; Creed, T. Michael; Eberly, Christian L.; Kingsbury, Tami J.; Baer, Maria R.; Kessler, Michael D.; Baylin, Stephen B.; Rassool, Feyruz, V
errShare
errSave
How Epigenetic Therapy Beats Adverse Genetics in Monosomy Karyotype AML
err2021-02-15
err0
errOAAI
errO'Hagan, Heather M.; Rassool, Feyruz V.; Nephew, Kenneth P.
errShare
errSave
Pharmacologic induction of innate immune signaling via STING directly drives homologous recombination deficiency
err2020-08-15
err0
PREAI
errMcLaughlin, Lena J.; Kogan, Aksinija A.; Baylin, Stephen B.; Topper, Michael J.; Rassool, Feyruz, V
errShare
errSave
Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency
err2020-07-10
err31
errOAAI
errMcLaughlin, Lena J.; Stojanovic, Lora; Kogan, Aksinija A.; Rutherford, Julia L.; Choi, Eun Yong; Yen, Ray-Whay Chiu; Xia, Limin; Zou, Ying; Lapidus, Rena G.; Baylin, Stephen B.; Topper, Michael J.; Rassool, Feyruz V.
errShare
errSave
Histone demethylase JMJD1A promotes expression of DNA repair factors and radio-resistance of prostate cancer cells
err2020-04-01
err34
errOAAI
errFan, Lingling; Xu, Songhui; Zhang, Fengbo; Cui, Xiaolu; Fazli, Ladan; Gleave, Martin; Clark, David J.; Yang, Austin; Hussain, Arif; Rassool, Feyruz; Qi, Jianfei
errShare
errSave
DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiation
err2019-10-07
err62
errOAAI
errAbbotts, Rachel; Topper, Michael J.; Biondi, Christopher; Fontaine, Daniel; Goswami, Reena; Stojanovic, Lora; Choi, Eun Yong; McLaughlin, Lena; Kogan, Aksinija A.; Xia, Limin; Lapidus, Rena; Mahmood, Javed; Baylin, Stephen B.; Rassool, Feyruz V.
errShare
errSave
Partnering with PARP inhibitors in acute myeloid leukemia with FLT3-ITD
err2019-07-01
err14
errOAAI
errDellomo, Anna J.; Baer, Maria R.; Rassool, Feyruz V.
errShare
errSave
DNMT and PARP inhibitor combination therapy induces an interferon-driven homologous recombination defect in triple-negative breast cancers and acute myeloid leukemia
err2019-07-01
err0
PREAI
errMcLaughlin, Lena J.; Kogan, Aksinija A.; Choi, Eun Yong; Lapidus, Rena S.; Zou, Ying; Li, Huili; Baylin, Stephen B.; Topper, Michael J.; Rassool, Feyruz V.
errShare
errSave
RETRACTION: Aromatase Inhibitor-mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer (Retraction of Vol 14, Pg 1728, 2015)
err2018-11-02
err1
errOAAI
errKhatri, Raju; Shah, Preeti; Guha, Rupa; Rassool, Feyruz V.; Tomkinson, Alan E.; Brodie, Angela; Jaiswal, Anil K.
errShare
errSave
DNA methyltransferase inhibitors sensitize NSCLC cells to PARP inhibitors by induction of a double strand break repair defect
err2018-07-01
err0
PREAI
errAbbotts, Rachel; Topper, Michael; Fontaine, Daniel; Biondi, Christopher; Choi, Eun Yong; Lapidus, Rena; Baylin, Stephen; Rassool, Feyruz
errShare
errSave
Combination of DNA methyltransferase and PARP inhibitors as a novel therapy strategy for multiple cancers: Key data in AML and triple negative breast cancer
err2017-11-14
err1
PREAI
errMuvarak, Nidal; Chowdhury, Khadiza; Robert, Carine; Xia Limin; Choi, Eun Yong; Cai, Yi; Bellani, Marina; Seidman, Michael; Baer, Maria R.; Lapidus, Rena; Baylin, Stephen B.; Rassool, Feyruz V.
errShare
errSave
Decreased Fanconi anemia gene expression contributes to efficacy of PARP and DNMT inhibitor combination therapy in triple negative breast cancer
err2017-07-01
err0
PREAI
errMcLaughlin, Lena J.; Li, Huili; Nagaria, Pratik; Baylin, Stephen B.; Zahnow, Cynthia A.; Rassool, Feyruz V.
errShare
errSave
The metastasis suppressor NME1 is recruited to DNA double strand breaks
err2017-07-01
err0
PREAI
errPuts, Gemma S.; Jarrett, Stuart G.; Snyder, Devin; Vincent, Richard; Wang, Ying; Leonard, Katie; Portney, Ben; Rassool, Feyruz; Zalzman, Michal; Kaetzel, David M.
errShare
errSave
Enhancing the therapeutic effects of PARP inhibitors in combination DNA methyl transferase inhibitors, using low doses of ionizing radiation in non small cell lung cancers
err2017-07-01
err0
PREAI
errBiondi, Christopher; Fontaine, Daniel; Stojanovic, Lora; Nagaria, Pratik; Lapidus, Rena; Choi, Eun Yong; Mahmood, Javed; Baylin, Stephen; Rassool, Feyruz V.
errShare
errSave